WPRIM Management System> DCMS> Kidney Research and Clinical Practice> 2016> 35

Volume: 35

1. Corrigendum: RNA sequencing of the nephron transcriptome: a technical note Volume 34, Issue 4, December 2015, Pages 219-227. Page:130—130
2. Is hypomagnesemia associated with using proton pump inhibitors?. Page:128—129
3. Relapsing lupus enteritis in systemic lupus erythematosus. Page:127—127
4. Successfully treated isolated renal artery pseudoaneurysm in a patient with Behçet's disease. Page:123—126
5. Renal artery stenosis presenting with nephrotic-range proteinuria: a case report. Page:119—122
6. Clinical significance of red blood cell distribution width in the prediction of mortality in patients on peritoneal dialysis. Page:114—118
7. Comparison of uremic pruritus between patients undergoing hemodialysis and peritoneal dialysis. Page:107—113
8. Predicting the probability of survival in acute paraquat poisoning. Page:102—106
9. PKD2 mutation in an Iranian autosomal dominant polycystic kidney disease family with misleading linkage analysis data. Page:96—101
10. Risk factors and outcomes of acute renal infarction. Page:90—95
11. The successful clinical outcomes of pregnant women with advanced chronic kidney disease. Page:84—89
12. Changes in urinary potassium excretion in patients with chronic kidney disease. Page:78—83
13. Adenosine monophosphate-activated protein kinase in diabetic nephropathy. Page:69—77
14. Genetic diagnosis of autosomal dominant polycystic kidney disease: linkage analysis versus direct mutation analysis. Page:67—68
15. Technique failure in Korean incident peritoneal dialysis patients: a national population-based study. Page:245—251
16. Pulmonary vein isolation alone and combined with renal sympathetic denervation in chronic kidney disease patients with refractory atrial fibrillation. Page:237—244
17. Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy. Page:233—236
18. Comparison of clinical characteristics of patients with acute kidney injury after intravenous versus inhaled colistin therapy. Page:229—232
19. Plasma renin activity and risk of cardiovascular and mortality outcomes among individuals with elevated and nonelevated blood pressure. Page:219—228
20. The role of local IL6/JAK2/STAT3 signaling in high glucose–induced podocyte hypertrophy. Page:212—218
21. Current characteristics of dialysis therapy in Korea: 2015 registry data focusing on elderly patients. Page:204—211
22. Diagnosis and treatment of patients with IgA nephropathy in Japan. Page:197—203
23. Interleukin-6 signaling in podocyte hypertrophy. Page:195—196
24. Bullous skin lesions in a patient with end-stage renal disease combined with myeloma and primary amyloidosis. Page:263—264
25. Crystalline podocytopathy and tubulopathy without overt glomerular proteinuria in a patient with multiple myeloma. Page:259—262
26. Unmasked chronic renal function deterioration after unilateral adrenalectomy in patients with primary aldosteronism. Page:255—258
27. Acute interstitial nephritis induced by Solanum nigrum. Page:252—254
28. Bilateral ureteral calcification with left kidney hydronephrosis in systemic lupus erythematosus. Page:65—66
29. Pulmonary hypertension in chronic kidney disease: what could change the fate?. Page:63—64
30. An unusual case of fistula formation and thrombosis between arteriovenous graft and a native vein. Page:59—62
31. Warfarin skin necrosis mimicking calciphylaxis in a patient with secondary hyperparathyroidism undergoing peritoneal dialysis. Page:55—58
32. Comparison of clinical outcomes between ABO-compatible and ABO-incompatible spousal donor kidney transplantation. Page:50—54
33. Assessment of the relationship between serum soluble Klotho and carotid intima-media thickness and left ventricular dysfunction in hemodialysis patients. Page:42—49
34. Clinical utility of far-infrared therapy for improvement of vascular access blood flow and pain control in hemodialysis patients. Page:35—41
35. Evaluating the association of interleukin-10 gene promoter -592 A/C polymorphism with lupus nephritis susceptibility. Page:29—34
36. Serum 25-hydroxyvitamin D as a predictor of hospitalization-free survival in predialysis and dialysis patients with chronic kidney disease: a single-center prospective observational analysis. Page:22—28
37. Direct vascular actions of quercetin in aorta from renal hypertensive rats. Page:15—21
38. Metabolic syndrome and obesity in peritoneal dialysis. Page:10—14
39. Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?. Page:3—9
40. Is Klotho deficiency independently associated with cardiovascular risk in chronic kidney disease?. Page:1—2
41. The authors reply. Page:193—193
42. The association between acute kidney injury in renal infarction and progression to chronic kidney disease. Page:192—192
43. Henoch–Schönlein purpura nephritis and colitis in an adult patient with alcoholic liver cirrhosis. Page:190—191
44. Cardiac arrest caused by nafamostat mesilate. Page:187—189
45. Rhabdomyolysis in a patient taking nebivolol. Page:182—186
46. High-level viruria as a screening tool for BK virus nephropathy in renal transplant recipients. Page:176—181
47. Low prealbumin levels are independently associated with higher mortality in patients on peritoneal dialysis. Page:169—175
48. Prevalence of hypothyroidism in patients with chronic kidney disease: a cross-sectional study from North India. Page:165—168
49. Predictive factors of acute kidney injury in patients undergoing rectal surgery. Page:160—164
50. Plasma endocan level and prognosis of immunoglobulin A nephropathy. Page:152—159
51. Elevated serum immunoglobulin E level as a marker for progression of immunoglobulin A nephropathy. Page:147—151
52. Cicletanine-induced hyponatremia and hypokalemia in kidney transplant patients. Page:142—146
53. Experimental systems to study the origin of the myofibroblast in peritoneal fibrosis. Page:133—141
54. Open the black box; is urine valuable for screening BK virus-associated nephropathy?. Page:131—132